Sitagliptin 100 mg + Dapagliflozin 10 mg + Metformin 500 mg Tablets – Advanced Triple Therapy for Type 2 Diabetes Management
- Sitagliptin 100 mg + Dapagliflozin 10 mg + Metformin 500 mg Tablets is an advanced triple-combination therapy formulated to provide comprehensive glycemic control in adults with Type 2 Diabetes Mellitus. By targeting three complementary mechanisms of action, it effectively helps reduce HbA1c, fasting blood glucose, and postprandial glucose levels while supporting long-term diabetes management. The formulation also promotes better patient compliance through convenient once-daily dosing and offers additional benefits such as weight management support with a low risk of hypoglycemia, along with cardiovascular and renal benefits in appropriate patients.
- Trulip Pharma is committed to delivering premium-quality pharmaceutical products that combine safety, efficacy, and affordability. We offer competitive pricing, attractive PCD Pharma franchise opportunities, monopoly rights, timely deliveries, and dependable customer support to help our business associates achieve sustainable growth.
- This product is manufactured by Logos Pharma in a WHO-GMP certified manufacturing facility under stringent quality standards, ensuring consistent safety, quality, and efficacy in every batch. Choose Trulip Pharma as your trusted partner for advanced diabetes care solutions and reliable pharmaceutical business opportunities.
